Mifepristona [Spanish] en es it fr

Categoria

Mifepristona [Spanish] Marchi, Mifepristona [Spanish] Analoghi

Mifepristona [Spanish] Marchi miscela

  • No information avaliable
  • Mifepristona [Spanish] Formula chimica

    C29H35NO2

    Mifepristona [Spanish] RX link

    http://www.rxlist.com/cgi/generic3/mifeprist.htm

    Mifepristona [Spanish] FDA foglio

    Mifepristona_[Spanish] FDA

    Mifepristona [Spanish] DMS (foglio di materiale di sicurezza)

    Mifepristona_[Spanish] MSDS

    Mifepristona [Spanish] Sintesi di riferimento

    Bidyasagar M. et al. Acta Crisalide. (1994) C50, 2089-2093

    Mifepristona [Spanish] Peso molecolare

    429.594 g/mol

    Mifepristona [Spanish] Temperatura di fusione

    191-196 oC

    Mifepristona [Spanish] H2O Solubilita

    scarsamente solubili

    Mifepristona [Spanish] Stato

    Solid

    Mifepristona [Spanish] LogP

    4.368

    Mifepristona [Spanish] Forme di dosaggio

    Compressa

    Mifepristona [Spanish] Indicazione

    Per l'interruzione medica di gravidanza intrauterina in gravidanza 49 giorni '.

    Mifepristona [Spanish] Farmacologia

    Il mifepristone è uno steroide sintetico con effetti antiprogestazionale indicato per l'interruzione medica di gravidanza intrauterina in gravidanza 49 giorni '. Dosi di 1 mg / kg o maggiore di mifepristone hanno dimostrato di antagonizzare gli effetti endometriale e miometriale del progesterone nelle donne. Durante la gravidanza, il composto sensibilizza il miometrio alla contrazione che induce l'attività di prostaglandine. Mifepristone anche mostre antiglucocorticoid e debole attività antiandrogena. L'attività del desametasone glucocorticoidi nel ratto è stata inibita a seguito di dosi da 10 a 25 mg / kg di mifepristone. . Dosi di 4,5 mg / kg o maggiore di esseri umani ha determinato un aumento compensatorio di ormone adrenocorticotropo (ACTH) e cortisolo.

    Mifepristona [Spanish] Assorbimento

    La biodisponibilità assoluta di una dose di 20 mg per via orale è del 69%

    Mifepristona [Spanish] Tossicita

    Quasi tutte le donne che ricevono mifepristone si riportano le reazioni avverse, e molti ci si può aspettare di segnalare più di una reazione del genere. Circa il 90% dei pazienti riportano le reazioni avverse a seguito della somministrazione di misoprostolo nel terzo giorno della procedura di trattamento. Gli effetti collaterali includono sanguinamento più pesante di un periodo di pesante manstrual, dolore addominale, crampi uterini, nausea, vomito e diarrea. .

    Mifepristona [Spanish] Informazioni paziente

    Patients should be fully advised of the treatment procedure and its effects. Patients should be given a copy of the MEDICATION GUIDE and the PATIENT AGREEMENT. (Additional copies of the MEDICATION GUIDE and the PATIENT AGREEMENT are available by contacting Danco Laboratories at 1-877-4 Early Option) (1-877-432-7596). Patients should be advised to review both the MEDICATION GUIDE and the PATIENT AGREEMENT, and should be given the opportunity to discuss them and obtain answers to any questions they may have prior to receiving Mifeprex. Patients should be advised to take their MEDICATION GUIDE with them if they visit an emergency room or another health care provider who did not prescribe Mifeprex, so that provider will be aware that the patient is undergoing a medical abortion.

    - the necessity of completing the treatment schedule, including a follow-up visit approximately 14 days after taking Mifeprex;

    - that vaginal bleeding and uterine cramping probably will occur;

    - that prolonged heavy vaginal bleeding is not proof of a complete abortion;

    - that if the treatment fails, there is a risk of fetal malformation;

    - that medical abortion treatment failures are managed by surgical termination; and

    - the steps to take in an emergency situation, including precise instructions and a telephone number that she can call if she has any problems or concerns.

    Another pregnancy can occur following termination of pregnancy and before resumption of normal menses. Contraception can be initiated as soon as the termination of the pregnancy has been confirmed, or before the woman resumes sexual intercourse.

    Patient information is included with each package of Mifeprex.


    MEDICATION GUIDE

    Mifeprex (MIF-eh-prex)
    (mifepristone)

    What is Mifeprex?

    Mifeprex is used to end an early pregnancy. It blocks a hormone needed for your pregnancy to continue. It is not approved for ending later pregnancies. Early pregnancy means it is 49 days (7 weeks) or less since your last menstrual period began. When you use Mifeprex (Day 1), you also need to take another medicine misoprostol, 2 days after you take Mifeprex (Day 3), to end your pregnancy. But, about 5-8 out of 100 women taking Mifeprex will need a surgical procedure to end the pregnancy or to stop too much bleeding.

    What is the most important information I should know about Mifeprex?

    What symptoms should I be concerned with? Although cramping and bleeding are an expected part of ending a pregnancy, rarely, serious and potentially life-threatening bleeding, infections, or other problems can occur following a miscarriage, surgical abortion, medical abortion, or childbirth. Prompt medical attention is needed in these cases. If you have any questions, concerns, or problems, or if you are worried about any side effects or symptoms, you should contact your provider. Your provider's telephone number is ________________________.

    Be sure to contact your provider promptly if you have any of the following:

    Heavy Bleeding. Contact your provider right away if you bleed enough to soak through two thick full-size sanitary pads per hour for two consecutive hours or if you are concerned about heavy bleeding. In about 1 out of 100 women, bleeding can be so heavy that it requires a surgical procedure (surgical abortion/D&C) to stop it.

    Severe Abdominal Pain or Fever. In the days after treatment, if you have severe abdominal pain or a fever of 100.4°F or higher that lasts for more than 4 hours, you should contact your provider right away. Severe abdominal pain or fever may be a symptom of a serious infection or another problem (including an ectopic pregnancy, a pregnancy outside the womb).

    Take this MEDICATION GUIDE with you. When you visit an emergency room or a provider who did not give you your Mifeprex, you should give them your MEDICATION GUIDE so that they understand that you are having a medical abortion with Mifeprex.

    What to do if you are still pregnant after Mifeprex with misoprostol treatment. If you are still pregnant, your provider will talk with you about the other choices you have, including a surgical procedure to end your pregnancy. There is a chance that there may be birth defects if the pregnancy is not ended.

    Talk with your provider. Before you take Mifeprex, you should read this MEDICATION GUIDE and sign a statement (PATIENT AGREEMENT). You and your provider should discuss the benefits and risks of your using Mifeprex.

    Who should not take Mifeprex?

    Some women should not take Mifeprex. Do not take it if:

    • It has been more than 49 days (7 weeks) since your last menstrual period began.
    • You have an IUD. It must be taken out before you take Mifeprex.
    • Your provider has told you that you have a pregnancy outside the uterus (ectopic pregnancy).
    • You have problems with your adrenal glands (chronic adrenal failure).
    • You take a medicine to thin your blood.
    • You have a bleeding problem.
    • You take certain steroid medicines.
    • You cannot return for the next 2 visits.
    • You cannot easily get emergency medical help in the 2 weeks after you take Mifeprex.
    • You are allergic to mifepristone, misoprostol, or medicines that contain misoprostol, such as Cytotec or Arthrotec.

    Tell your provider about all your medical conditions to find out if you can take Mifeprex. Also, tell your provider if you smoke at least 10 cigarettes a day.

    How should I take Mifeprex?

    • Day 1 at your provider's office:
      • Read this MEDICATION GUIDE.
      • Discuss the benefits and risks of using Mifeprex to end your pregnancy.
      • If you decide Mifeprex is right for you, sign the PATIENT AGREEMENT.
      • After getting a physical exam, swallow 3 tablets of Mifeprex.
    • Day 3 at your provider's office:
      • If you are still pregnant, take 2 misoprostol tablets.
      • Misoprostol may cause cramps, nausea, diarrhea, and other symptoms. Your provider may send you home with medicines for these symptoms.
    • About Day 14 at your provider's office:
      • This follow-up visit is very important. You must return to the provider about 14 days after you have taken Mifeprex to be sure you are well and that you are not pregnant.
      • Your provider will check whether your pregnancy has completely ended. If it has not ended, there is a chance that there may be birth defects. If you are still pregnant, your provider will talk with you about the other choices you have, including a surgical procedure to end your pregnancy.

    What should I avoid while taking Mifeprex and misoprostol?

    Do not take any other prescription or non-prescription medicines (including herbal medicines or supplements) at any time during the treatment period without first asking your provider about them because they may interfere with the treatment. Ask your provider about what medicines you can take for pain.

    If you are breastfeeding at the time you take Mifeprex and misoprostol, discuss with your provider if you should stop breastfeeding for a few days.

    What are the possible and reasonably likely side effects of Mifeprex?

    Cramping and bleeding are expected with this treatment. Usually, these symptoms mean that the treatment is working. But sometimes you can get cramping and bleeding and still be pregnant. This is why you must return to your provider on Day 3 and about Day 14. See ìHow should I take Mifeprex?î for more information on when to return to your provider. If you are not already bleeding after taking Mifeprex, you probably will begin to bleed once you take misoprostol, the medicine you take on Day 3. Bleeding or spotting can be expected for an average of 9ñ16 days and may last for up to 30 days. Your bleeding may be similar to, or greater than, a normal heavy period. You may see blood clots and tissue. This is an expected part of ending the pregnancy.

    Other common symptoms of treatment include diarrhea, nausea, vomiting, headache, dizziness, back pain, and tiredness. These side effects lessen after Day 3 and are usually gone by Day 14. Your provider will tell you how to manage any pain or other side effects.

    When should I begin birth control?

    You can become pregnant again right after your pregnancy ends. If you do not want to become pregnant again, start using birth control as soon as your pregnancy ends or before you start having sexual intercourse again.

    *   *   *

    Medicines are sometimes prescribed for purposes other than those listed in a MEDICATION GUIDE. For more information, ask your provider for the information about Mifeprex that is written for health care professionals. Ask your provider if you have any questions.

    This MEDICATION GUIDE has been approved by the U.S. Food and Drug Administration.


    PATIENT AGREEMENT

    Mifeprex (mifepristone) Tablets

    1. I have read the attached MEDICATION GUIDE for using Mifeprex and misoprostol to end my pregnancy.

    2. I discussed the information with my health care provider (provider).

    3. My provider answered all my questions and told me about the risks and benefits of using Mifeprex and misoprostol to end my pregnancy.

    4. I believe I am no more than 49 days (7 weeks) pregnant.

    5. I understand that I will take Mifeprex in my provider's office (Day 1).

    6. I understand that I will take misoprostol in my provider's office two days after I take Mifeprex (Day 3).

    7. My provider gave me advice on what to do if I develop heavy bleeding or need emergency care due to the treatment.

    8. Bleeding and cramping do not mean that my pregnancy has ended. Therefore, I must return to my provider's office in about 2 weeks (about Day 14) after I take Mifeprex to be sure that my pregnancy has ended and that I am well.

    9. I know that, in some cases, the treatment will not work. This happens in about 5 to 8 women out of 100 who use this treatment.

    10. I understand that if my pregnancy continues after any part of the treatment, there is a chance that there may be birth defects. If my pregnancy continues after treatment with Mifeprex and misoprostol, I will talk with my provider about my choices, which may include a surgical procedure to end my pregnancy.

    11. I understand that if the medicines I take do not end my pregnancy and I decide to have a surgical procedure to end my pregnancy, or if I need a surgical procedure to stop bleeding, my provider will do the procedure or refer me to another provider who will. I have that provider's name, address and phone number.

    12. I have my provider's name, address and phone number and know that I can call if I have any questions or concerns.

    13. I have decided to take Mifeprex and misoprostol to end my pregnancy and will follow my provider's advice about when to take each drug and what to do in an emergency.

    14. I will do the following:

    • contact my provider right away if in the days after treatment I have a fever of 100.4°F or higher that lasts for more than 4 hours or severe abdominal pain.
    • contact my provider right away if I have heavy bleeding (soaking through two thick full-size sanitary pads per hour for two consecutive hours).
    • take the MEDICATION GUIDE with me when I visit an emergency room or a provider who did not give me Mifeprex, so that they will understand that I am having a medical abortion with Mifeprex.
    • return to my provider's office in 2 days (Day 3) to check if my pregnancy has ended. My provider will give me misoprostol if I am still pregnant.
    • return to my provider's office about 14 days after beginning treatment to be sure that my pregnancy has ended and that I am well

    Patient Signature: _________________________________

    Patient Name (print): ______________________________

    Date: ______________________________

    The patient signed the PATIENT AGREEMENT in my presence after I counseled her and answered all her questions. I have given her the MEDICATION GUIDE for mifepristone.

    Provider's Signature: ______________________________

    Name of Provider (print): __________________________

    Date: __________________________________

    After the patient and the provider sign this PATIENT AGREEMENT, give 1 copy to the patient before she leaves the office and put 1 copy in her medical record. Give a copy of the MEDICATION GUIDE to the patient.

    Mifepristona [Spanish] Atto interessato organismi

    Gli esseri umani e altri mammiferi